18
Participants
Start Date
April 3, 2024
Primary Completion Date
October 18, 2024
Study Completion Date
October 18, 2024
Cessation Intervention
"1. Pharmacotherapy selection, prescription and monitoring of up to two types of cessation pharmacotherapies: Nicotine replacement therapy (gum, lozenge and transdermal patch) and non-nicotine replacement therapy (varenicline).~2. Remote video-conferencing and mobile phone-based, personalized motivational messaging"
Creative Alternative, Baltimore
National Center for Advancing Translational Sciences (NCATS)
NIH
Community Partnership and Collaboration Core Pilot Grant
UNKNOWN
Johns Hopkins University
OTHER